{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T10:40:00Z","timestamp":1774953600731,"version":"3.50.1"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lungcancerjournal.info","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.lungcan.2018.07.002","type":"journal-article","created":{"date-parts":[[2018,7,4]],"date-time":"2018-07-04T02:25:13Z","timestamp":1530671113000},"page":"142-148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Stereotactic ablative radiotherapy (SABR) for early-stage central lung tumors: New insights and approaches"],"prefix":"10.1016","volume":"123","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2232-0641","authenticated-orcid":false,"given":"H.","family":"Tekatli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.O.B.","family":"Spoelstra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Palacios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"van Sornsen de Koste","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.J.","family":"Slotman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Senan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.lungcan.2018.07.002_bib0005","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1001\/jamaoncol.2016.5688","article-title":"Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study global burden","volume":"3","author":"Fitzmaurice","year":"2017","journal-title":"JAMA Oncol."},{"issue":"suppl_4","key":"10.1016\/j.lungcan.2018.07.002_bib0010","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/annonc\/mdx222","article-title":"Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO clinical practice guidelines for diagnosis, treatment and follow-up\u2020","volume":"28","author":"Postmus","year":"2017","journal-title":"Ann. Oncol."},{"issue":"35","key":"10.1016\/j.lungcan.2018.07.002_bib0015","doi-asserted-by":"crossref","first-page":"5153","DOI":"10.1200\/JCO.2010.30.0731","article-title":"Impact of introducing stereotactic lung radiotherapy for elderly patients with stage I non\u2013small-cell lung cancer: a population-based time-trend analysis","volume":"28","author":"Palma","year":"2010","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.lungcan.2018.07.002_bib0020","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1093\/annonc\/mds081","article-title":"Early-stage lung cancer in elderly patients: a population-based study of changes in treatment patterns and survival in the Netherlands","volume":"23","author":"Haasbeek","year":"2012","journal-title":"Ann. Oncol."},{"issue":"0","key":"10.1016\/j.lungcan.2018.07.002_bib0025","first-page":"3136","article-title":"Stereotactic body radiation therapy for early-stage non-small cell lung cancer: executive summary of an ASTRO evidence-based guideline","volume":"30","author":"Videtic","year":"2017","journal-title":"Pract. Radiat. Oncol."},{"key":"10.1016\/j.lungcan.2018.07.002_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2017.05.012","article-title":"ESTRO ACROP consensus guideline on implementation and practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer","author":"Guckenberger","year":"2017","journal-title":"Radiother. Oncol."},{"issue":"2","key":"10.1016\/j.lungcan.2018.07.002_bib0035","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/ejcts\/ezx410","article-title":"The great debate flashes: surgery versus stereotactic body radiotherapy as the primary treatment of early-stage lung cancer","volume":"53","author":"Weder","year":"2018","journal-title":"Eur. J. Cardio-Thoracic Surg."},{"issue":"30","key":"10.1016\/j.lungcan.2018.07.002_bib0040","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.1200\/JCO.2006.07.5937","article-title":"Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer","volume":"24","author":"Timmerman","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2018.07.002_bib0045","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.lungcan.2008.12.016","article-title":"Fractionated stereotactic body radiation therapy for medically inoperable stage I lung cancer adjacent to central large bronchus","volume":"66","author":"Song","year":"2009","journal-title":"Lung Cancer"},{"issue":"3","key":"10.1016\/j.lungcan.2018.07.002_bib0050","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.radonc.2013.01.004","article-title":"Outcomes of stereotactic ablative radiotherapy for central lung tumours: a systematic review","volume":"106","author":"Senthi","year":"2013","journal-title":"Radiother. Oncol."},{"issue":"11","key":"10.1016\/j.lungcan.2018.07.002_bib0055","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1001\/jama.2010.261","article-title":"Stereotactic body radiation therapy for inoperable early stage lung cancer","volume":"303","author":"Timmerman","year":"2010","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.lungcan.2018.07.002_bib0060","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ijrobp.2008.11.042","article-title":"Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: Four-year results of a prospective phase II study","volume":"75","author":"Fakiris","year":"2009","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.lungcan.2018.07.002_bib0065","doi-asserted-by":"crossref","first-page":"S340","DOI":"10.1016\/j.jtho.2016.11.369","article-title":"OA24.05 the nordic HILUS-trial - first report of a phase II trial of SBRT of centrally located lung tumors","volume":"12","author":"Lindberg","year":"2017","journal-title":"J. Thorac. Oncol."},{"issue":"1","key":"10.1016\/j.lungcan.2018.07.002_bib0070","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.lungcan.2015.04.014","article-title":"Stereotactic ablative radiotherapy (SABR) for treatment of central and ultra-central lung tumors","volume":"89","author":"Chaudhuri","year":"2015","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/j.lungcan.2018.07.002_bib0075","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s13014-016-0732-5","article-title":"SBRT for centrally localized NSCLC\u2013what is too central?","volume":"11","author":"Roesch","year":"2016","journal-title":"Radiat. Oncol."},{"issue":"1","key":"10.1016\/j.lungcan.2018.07.002_bib0080","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.radonc.2015.09.028","article-title":"Stereotactic ablative radiotherapy (SABR) for central lung tumors: plan quality and long-term clinical outcomes","volume":"117","author":"Tekatli","year":"2015","journal-title":"Radiother. Oncol."},{"issue":"7","key":"10.1016\/j.lungcan.2018.07.002_bib0085","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jtho.2016.03.008","article-title":"Outcomes of hypofractionated high-dose radiotherapy in poor-risk patients with \u201cUltracentral\u201d non\u2013small cell lung cancer","volume":"11","author":"Tekatli","year":"2016","journal-title":"J. Thorac. Oncol."},{"issue":"4","key":"10.1016\/j.lungcan.2018.07.002_bib0090","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.ijrobp.2016.12.022","article-title":"Stereotactic ablative radiation therapy is highly safe and effective for elderly patients with early-stage non-small cell lung cancer","volume":"98","author":"Brooks","year":"2017","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"8","key":"10.1016\/j.lungcan.2018.07.002_bib0095","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/S1470-2045(12)70242-5","article-title":"Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis","volume":"13","author":"Senthi","year":"2012","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.lungcan.2018.07.002_bib0100","first-page":"967","article-title":"Stereotactic body radiotherapy for early-stage non\u2013small-cell lung cancer: American society of clinical oncology endorsement of the American society for radiation oncology evidence-based guideline","volume":"74","author":"Schneider","year":"2017","journal-title":"J. Clin. Oncol."},{"issue":"suppl 61","key":"10.1016\/j.lungcan.2018.07.002_bib0105","article-title":"Complete endosonographic nodal staging of lung cancer in patients eligible for stereotactic ablative radiotherapy (STAGE study NCT02997449)","volume":"50","author":"Crombag","year":"2017","journal-title":"Eur. Respir. J."},{"issue":"12","key":"10.1016\/j.lungcan.2018.07.002_bib0110","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.5858\/arpa.2011-0521-OA","article-title":"Causes of death of patients with lung cancer","volume":"136","author":"Nichols","year":"2012","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"34","key":"10.1016\/j.lungcan.2018.07.002_bib0115","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.1200\/JCO.2013.51.5353","article-title":"Dose-limiting toxicity after hypofractionated dose-escalated radiotherapy in non-small-cell lung cancer","volume":"31","author":"Cannon","year":"2013","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.lungcan.2018.07.002_bib0120","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0360-3016(97)00008-4","article-title":"Does additional brachytherapy improve the effect of external irradiation? A prospective, randomized study in central lung tumors","volume":"38","author":"Huber","year":"1997","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"2","key":"10.1016\/j.lungcan.2018.07.002_bib0125","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0167-8140(98)00103-0","article-title":"Massive haemoptysis after radiotherapy in inoperable non-small cell lung carcinoma: is endobronchial brachytherapy really a risk factor?","volume":"49","author":"Langendijk","year":"1998","journal-title":"Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol."},{"issue":"3","key":"10.1016\/j.lungcan.2018.07.002_bib0130","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1183\/09031936.00010114","article-title":"Severe haemoptysis in patients with nonsmall cell lung carcinoma","volume":"45","author":"Razazi","year":"2015","journal-title":"Eur. Respir. J."},{"issue":"6","key":"10.1016\/j.lungcan.2018.07.002_bib0135","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/01.coc.0000182428.56184.af","article-title":"Stereotactic body radiation therapy of lung tumors: preliminary experience using normal tissue complication probability-based dose limits","volume":"28","author":"Song","year":"2005","journal-title":"Am. J. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.lungcan.2018.07.002_bib0140","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1097\/JTO.0b013e31822e71d8","article-title":"Outcomes of stereotactic ablative radiotherapy for centrally located early-stage lung cancer","volume":"6","author":"Haasbeek","year":"2011","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2018.07.002_bib0145","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.ijrobp.2013.06.2055","article-title":"Retrospective cohort study of bronchial doses and radiation-induced atelectasis after stereotactic body radiation therapy of lung tumors located close to the bronchial tree","volume":"87","author":"Karlsson","year":"2013","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"9","key":"10.1016\/j.lungcan.2018.07.002_bib0150","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1097\/JTO.0000000000000260","article-title":"Toxicities of organs at risk in the mediastinal and hilar regions following stereotactic body radiotherapy for","volume":"9","author":"Nishimura","year":"2014","journal-title":"J. Thorac. Oncol."},{"issue":"3","key":"10.1016\/j.lungcan.2018.07.002_bib0155","first-page":"878","article-title":"Oligometastases treated with stereotactic body radiotherapy: long-term follow-up of prospective study","volume":"83","author":"Milano","year":"2012","journal-title":"Radiat. Oncol."},{"issue":"4","key":"10.1016\/j.lungcan.2018.07.002_bib0160","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/JTO.0000000000000453","article-title":"IASLC advanced radiation technology committee. Stereotactic ablative radiotherapy for centrally located early stage non-small-cell lung cancer: what we have learned","volume":"10","author":"Chang","year":"2015","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2018.07.002_bib0165","article-title":"Local control and toxicity in a large cohort of central lung tumors treated with stereotactic body radiation therapy","author":"Modh","year":"2014","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.lungcan.2018.07.002_bib0170","first-page":"1","article-title":"Central vs. peripheral tumor location","author":"Park","year":"2015","journal-title":"J. Thorac. Oncol."},{"issue":"2","key":"10.1016\/j.lungcan.2018.07.002_bib0175","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1016\/j.prro.2015.09.012","article-title":"Fatal complications after stereotactic body radiation therapy for central lung tumors abutting the proximal bronchial tree","volume":"6","author":"Haseltine","year":"2018","journal-title":"Pract. Radiat. Oncol."},{"issue":"2","key":"10.1016\/j.lungcan.2018.07.002_bib0180","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.radonc.2011.09.012","article-title":"Toxicity after reirradiation of pulmonary tumours with stereotactic body radiotherapy","volume":"101","author":"Peulen","year":"2011","journal-title":"Radiother. Oncol."},{"issue":"3","key":"10.1016\/j.lungcan.2018.07.002_bib0185","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.ijrobp.2017.11.022","article-title":"Normal tissue complication probability (NTCP) modelling of pulmonary toxicity after stereotactic and hypo-fractionated radiotherapy for central lung tumors","volume":"100","author":"Tekatli","year":"2017","journal-title":"Int. J. Radiat. Oncol."},{"key":"10.1016\/j.lungcan.2018.07.002_bib0190","first-page":"10","article-title":"Specific toxicity after stereotactic body radiation therapy to the central chest: a comprehensive review","author":"Oskan","year":"2016","journal-title":"Strahlenther. Onkol."},{"issue":"4","key":"10.1016\/j.lungcan.2018.07.002_bib0195","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0954-6111(95)90090-X","article-title":"The incidence of airflow obstruction in bronchial carcinoma, its relation to breathlessness, and response to bronchodilator therapy","volume":"89","author":"Congleton","year":"1995","journal-title":"Respir. Med."},{"issue":"5","key":"10.1016\/j.lungcan.2018.07.002_bib0200","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1378\/chest.129.5.1305","article-title":"Prevalence of COPD in women compared to men around the time of diagnosis of primary lung cancer","volume":"129","author":"Loganathan","year":"2006","journal-title":"Chest"},{"issue":"8","key":"10.1016\/j.lungcan.2018.07.002_bib0205","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S2213-2600(15)00241-6","article-title":"Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis","volume":"3","author":"Chen","year":"2015","journal-title":"Lancet Respir. Med."},{"issue":"10","key":"10.1016\/j.lungcan.2018.07.002_bib0210","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1164\/rccm.201207-1299OC","article-title":"Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general population","volume":"186","author":"Lange","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.lungcan.2018.07.002_bib0215","series-title":"Chronic Obstructive Pulmonary disease and Sudden Cardiac Death: the Rotterdam Study","author":"Lahousse","year":"2015"},{"key":"10.1016\/j.lungcan.2018.07.002_bib0220","doi-asserted-by":"crossref","first-page":"S187","DOI":"10.1016\/S0167-8140(16)31648-6","article-title":"OC-0399: dose to heart substructures is associated with non-cancer death after SBRT in stage I NSCLC patients","volume":"119","author":"Stam","year":"2016","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.lungcan.2018.07.002_bib0225","first-page":"1","article-title":"Cardiac dose and survival after stereotactic body radiotherapy for early-stage non-small-cell lung cancer","author":"Tembhekar","year":"2016","journal-title":"Clin. Lung Cancer"},{"issue":"216","key":"10.1016\/j.lungcan.2018.07.002_bib0230","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ijrobp.2014.05.011","article-title":"Esophageal dose tolerance to hypofractionated stereotactic body radiation therapy: risk factors for late toxicity","volume":"90","author":"Stephans","year":"2014","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"2","key":"10.1016\/j.lungcan.2018.07.002_bib0235","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.radonc.2014.07.001","article-title":"Dosimetric predictors of esophageal toxicity after stereotactic body radiotherapy for central lung tumors","volume":"112","author":"Wu","year":"2014","journal-title":"Radiother. Oncol."},{"issue":"1","key":"10.1016\/j.lungcan.2018.07.002_bib0240","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s13014-016-0693-8","article-title":"A critical review of recent developments in radiotherapy for non-small cell lung cancer","volume":"11","author":"Baker","year":"2016","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.lungcan.2018.07.002_bib0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2018.02.025","article-title":"Low incidence of esophageal toxicity following lung SBRT: are current esophageal dose constraints too conservative?","author":"Yau","year":"2018","journal-title":"Int. J. Radiat. Oncol."},{"key":"10.1016\/j.lungcan.2018.07.002_bib0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2018.02.004","article-title":"Esophagus toxicity after stereotactic and hypofractionated radiotherapy for central lung tumors: normal tissue complication probability modelling","author":"Duijm","year":"2018","journal-title":"Radiother. Oncol."},{"issue":"3 Suppl","key":"10.1016\/j.lungcan.2018.07.002_bib0255","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1016\/j.ijrobp.2009.05.070","article-title":"Radiation dose-volume effects in the esophagus","volume":"76","author":"Werner-Wasik","year":"2010","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"4","key":"10.1016\/j.lungcan.2018.07.002_bib0260","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.ijrobp.2013.07.029","article-title":"Predicting esophagitis after chemoradiation therapy for non-small cell lung cancer: an individual patient data meta-analysis","volume":"87","author":"Palma","year":"2013","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"3","key":"10.1016\/j.lungcan.2018.07.002_bib0265","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ijrobp.2015.02.016","article-title":"Gastrointestinal toxicities with combined antiangiogenic and stereotactic body radiation therapy","volume":"92","author":"Pollom","year":"2015","journal-title":"Int. J. Radiat. Oncol."},{"issue":"11","key":"10.1016\/j.lungcan.2018.07.002_bib0270","doi-asserted-by":"crossref","first-page":"S1853","DOI":"10.1016\/j.jtho.2017.09.565","article-title":"MA 13.07 a randomized trial of SABR vs conventional radiotherapy for inoperable stage I non-small cell lung cancer: TROG09.02 (CHISEL)","volume":"12","author":"Ball","year":"2017","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2018.07.002_bib0275","doi-asserted-by":"crossref","DOI":"10.6004\/jnccn.2017.0050","article-title":"NCCN guidelines version 4.2017 panel members non-small cell lung cancer","author":"Ettinger","year":"2017","journal-title":"Nat. Comp. Cancer Netw."},{"issue":"5","key":"10.1016\/j.lungcan.2018.07.002_bib0280","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.ijrobp.2014.01.022","article-title":"Stereotactic ablative radiation therapy for centrally located early stage or isolated parenchymal recurrences of non-small cell lung cancer: how to fly in a \u201cno fly zone.\u201d","volume":"88","author":"Chang","year":"2014","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.lungcan.2018.07.002_bib0285","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ijrobp.2006.04.013","article-title":"Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable stage I\/II non-small-cell lung cancer","volume":"66","author":"Xia","year":"2006","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"2","key":"10.1016\/j.lungcan.2018.07.002_bib0290","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.radonc.2012.09.008","article-title":"Is high-dose stereotactic body radiotherapy (SBRT) for stage I non-small cell lung cancer (NSCLC) overkill? A systematic review","volume":"105","author":"Baardwijk","year":"2012","journal-title":"Radiother. Oncol."},{"issue":"7","key":"10.1016\/j.lungcan.2018.07.002_bib0295","doi-asserted-by":"crossref","first-page":"934","DOI":"10.3109\/0284186X.2015.1136754","article-title":"An analysis of planned versus delivered airway doses during stereotactic lung radiotherapy for central tumors","volume":"55","author":"Dahele","year":"2016","journal-title":"Acta Oncol. (Madr.)"},{"issue":"3","key":"10.1016\/j.lungcan.2018.07.002_bib0300","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.semradonc.2014.02.008","article-title":"The ViewRay system: magnetic resonance\u2013guided and controlled radiotherapy","volume":"24","author":"Mutic","year":"2014","journal-title":"Semin. Radiat. Oncol."},{"issue":"3","key":"10.1016\/j.lungcan.2018.07.002_bib0305","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.adro.2017.05.006","article-title":"Two-and-a-half-year clinical experience with the world\u2019s first magnetic resonance image guided radiation therapy system","volume":"2","author":"Fischer-Valuck","year":"2017","journal-title":"Adv. Radiat. Oncol."},{"issue":"1083","key":"10.1016\/j.lungcan.2018.07.002_bib0310","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20170522","article-title":"Initial clinical observations of intra- and interfractional motion variation in MR-guided lung SBRT","volume":"91","author":"Thomas","year":"2018","journal-title":"Br. J. Radiol."},{"issue":"8","key":"10.1016\/j.lungcan.2018.07.002_bib0315","first-page":"e1618","article-title":"Online adaptive radiation therapy: implementation of a new process of care","volume":"9","author":"Lamb","year":"2017","journal-title":"Cureus"},{"key":"10.1016\/j.lungcan.2018.07.002_bib0320","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.2236","article-title":"Patient-reported outcome measurements on the tolerance of magnetic resonance imaging-guided radiation therapy","author":"Tetar","year":"2018","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.lungcan.2018.07.002_bib0325","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1118\/1.4938096","article-title":"SIFT-based dense pixel tracking on 0.35 T cine-MR images acquired during image-guided radiation therapy with application to gating optimization","volume":"43","author":"Mazur","year":"2016","journal-title":"Med. Phys."},{"key":"10.1016\/j.lungcan.2018.07.002_bib0330","article-title":"A phase II study of stereotactic body radiotherapy and stereotactic body proton therapy for high-risk medically inoperable early-stage non-small cell lung cancer","author":"Li","year":"2018","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.lungcan.2018.07.002_bib0335","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1186\/s12885-015-1974-6","article-title":"A patient perspective on shared decision making in stage I non-small cell lung cancer: a mixed methods study","volume":"15","author":"Hopmans","year":"2015","journal-title":"BMC Cancer"},{"issue":"7","key":"10.1016\/j.lungcan.2018.07.002_bib0340","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2017.75.6536","article-title":"Post-treatment mortality after surgery and stereotactic body radiotherapy for early-stage non\u2013small-cell lung cancer","volume":"36","author":"Stokes","year":"2018","journal-title":"J. Clin. Oncol."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500218304598?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500218304598?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T22:50:06Z","timestamp":1720392606000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500218304598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":68,"alternative-id":["S0169500218304598"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2018.07.002","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stereotactic ablative radiotherapy (SABR) for early-stage central lung tumors: New insights and approaches","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2018.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}